SHINE Medical Technologies

company

About

SHINE Medical Technologies manufactures and supplies medical tracers and cancer treatment elements.

  • 101 - 250

Details

Last Funding Type
Series B
Industries
Biotechnology,Health Care,Manufacturing,Medical,Medical Device
Founded date
Jan 1, 2010
Number Of Employee
101 - 250
Operating Status
Active

SHINE Medical Technologies, Inc. manufactures and supplies medical tracers and cancer treatment elements. The company offers Molybdenum-99, a light-emitting element that is administered to patients for the purpose of diagnosing and staging cancer and heart diseases. It also provides Iodine-131 that is used to treat thyroid cancer and various abnormal thyroid conditions, including hyperthyroidism, as well as to diagnose liver function, renal blood flow, and urinary tract obstruction.

The company was founded in 2010 and is headquartered in Janesville, Wisconsin.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$149.74K
SHINE Medical Technologies has raised a total of $149.74K in funding over 2 rounds. Their latest funding was raised on Apr 18, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 18, 2018 Series B 3 Detail
Jun 24, 2015 Grant $149.74K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
3
SHINE Medical Technologies is funded by 3 investors. US Department of Energy and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
US Department of Energy Series B
National Science Foundation Series B
Knox Series B